Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Between-group comparison showed that the treatment-induced change in 25(OH)D (Δ25(OH)D) was significantly greater in responders (P = 0.008), who also demonstrated larger improvements in clinical activity score (CAS), NOSPECS score, and diplopia.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study
Source: Article title.
All patients were over 18 years old and were diagnosed with TAO by a professional clinician based on clinical manifestations and the orbital CT results.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study
Cohort study · Frontiers in Immunology · 2026
Original publication title
Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study
Copyright © 2026 Wang, Wang, Xu, Sun, Zhou, Chen, Zhao, Zhang, Guo, Shi, Wang and Zhang.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Intravenous glucocorticoids (IVGC) represent first-line therapy for active moderate-to-severe thyroid-associated ophthalmopathy (TAO). The relationship between vitamin D (VitD) and IVGC efficacy in TAO remains undefined.
Source: BackgroundAbstract: What methods does the paper describe?
This retrospective study grouped TAO patients completing IVGC therapy with standardized VitD/calcium supplementation at First Affiliated Hospital of Xi’an Jiaotong University (2015 to 2019). Serum 25-hydroxyvitamin D (25(OH)D) and bone markers were measured pre/post-treatment. Multivariate regression and ROC analysis identified predictors.
Source: MethodsAbstract: Results
In total, 52 TAO patients were enrolled, including 33 responders and 19 non-responders. Non-responders had significantly higher baseline triglycerides, thyroxine and longer duration of ophthalmopathy. Responders exhibited higher baseline β-CTX and N-MID OC. Notably, 73.08% of patients had baseline 25(OH)D deficiency (<20 ng/mL), with a significant 25(OH)D increase observed only in responders (P = 0.02). Between-group comparison showed that the treatment-induced change in 25(OH)D (Δ25(OH)D) was significantly greater in responders (P = 0.008), who also demonstrated larger improvements in clinical activity score (CAS), NOSPECS score, and diplopia.
Multivariate analysis confirmed Δ25(OH)D as an independent predictor after adjustment for confounders (adjusted OR = 1.205, 95% CI:1.033 to 1.405; P = 0.017). ROC analysis showed Δ25(OH)D predicted response (AUC = 0.732, P = 0.006), with an optimal cutoff of +2.7 ng/mL. Predictive power was enhanced in males, patients ≥50 years, and baseline 25(OH)D: deficient subgroups.
Source: ResultsAbstract: Conclusion
Δ25(OH)D is an independent predictor of IVGC response in TAO. Monitoring dynamic changes in serum 25(OH)D during therapy and targeting a minimum increase of 2.7 ng/mL may be associated with improved treatment outcomes, particularly in male, elderly, and VitD-deficient subpopulations.
Source: ConclusionAuthors’ abstract
Background
Intravenous glucocorticoids (IVGC) represent first-line therapy for active moderate-to-severe thyroid-associated ophthalmopathy (TAO). The relationship between vitamin D (VitD) and IVGC efficacy in TAO remains undefined.
Methods
This retrospective study grouped TAO patients completing IVGC therapy with standardized VitD/calcium supplementation at First Affiliated Hospital of Xi’an Jiaotong University (2015 to 2019). Serum 25-hydroxyvitamin D (25(OH)D) and bone markers were measured pre/post-treatment. Multivariate regression and ROC analysis identified predictors.
Results
In total, 52 TAO patients were enrolled, including 33 responders and 19 non-responders. Non-responders had significantly higher baseline triglycerides, thyroxine and longer duration of ophthalmopathy. Responders exhibited higher baseline β-CTX and N-MID OC. Notably, 73.08% of patients had baseline 25(OH)D deficiency (<20 ng/mL), with a significant 25(OH)D increase observed only in responders (P = 0.02). Between-group comparison showed that the treatment-induced change in 25(OH)D (Δ25(OH)D) was significantly greater in responders (P = 0.008), who also demonstrated larger improvements in clinical activity score (CAS), NOSPECS score, and diplopia.
Multivariate analysis confirmed Δ25(OH)D as an independent predictor after adjustment for confounders (adjusted OR = 1.205, 95% CI:1.033 to 1.405; P = 0.017). ROC analysis showed Δ25(OH)D predicted response (AUC = 0.732, P = 0.006), with an optimal cutoff of +2.7 ng/mL. Predictive power was enhanced in males, patients ≥50 years, and baseline 25(OH)D: deficient subgroups.
Conclusion
Δ25(OH)D is an independent predictor of IVGC response in TAO. Monitoring dynamic changes in serum 25(OH)D during therapy and targeting a minimum increase of 2.7 ng/mL may be associated with improved treatment outcomes, particularly in male, elderly, and VitD-deficient subpopulations.
Publication and source details
Original title: Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study
Ling Wang; Jingya Wang; Huayang Xu; Yushi Sun; Xingchen Zhou; Yu Chen; Jiarui Zhao; Jinbo Zhang; Hui Guo; Bingyin Shi; Yue Wang; Meng Zhang
Frontiers in Immunology · 2026
* Correspondence: Meng Zhang, mengbaba19921025@163.com†ORCID: Meng Zhang, orcid.org/0000-0002-4640-8891
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:23:05.287968+00:00
DOI: 10.3389/fimmu.2026.1778702 · PMC13139022